A company has acquired a DNA vaccine for Alzheimer’s disease that is designed to trigger an immune response to the disease. The vaccine, in preclinical development, differs from other Alzheimer’s vaccines under study in that it only contains a piece of the coding for the amyloid beta protein, a company statement said. Amyloid beta in […]
Meningitis vaccine HibTITER, acquired from Wyeth, has been licensed to Mitsubishi Tanabe Pharma Corp. for the Japanese market. Nuron Biotech acquired the vaccine from Wyeth, a subsidiary of Pfizer (NYSE:PFE) in January of last year. Wyeth stopped making the vaccine in 2004, according to a spokesman for the Exton, Pennsylvania-based biologics and vaccines company. Currently, the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.